Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Clin Exp Nephrol
2016 Aug 01;204:578-584. doi: 10.1007/s10157-015-1186-z.
Show Gene links
Show Anatomy links
Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2.
Mancikova A
,
Krylov V
,
Hurba O
,
Sebesta I
,
Nakamura M
,
Ichida K
,
Stiburkova B
.
???displayArticle.abstract???
BACKGROUND: Renal hypouricemia is a rare heterogeneous inherited disorder characterized by impaired tubular uric acid transport with severe complications, such as acute kidney injury and nephrolithiasis. Type 1 is caused by a loss-of-function mutation in the SLC22A12 gene (URAT1), while type 2 is caused by defects in the SLC2A9 gene (GLUT9).
METHODS AND RESULTS: In this article we present clinical, biochemical and molecular genetics of two Czech patients. The serum uric acid in the probands was 57 and 98 µmol/l and expressed as an increase in the fractional excretion of uric acid (40 and 18 %). The sequencing analysis of SLC22A12 and SLC2A9 revealed novel variants p.R92C and p.R203C in URAT1 and p.G72D in GLUT9. Functional studies were performed for these novel variants and for previously reported variants p.I118HfsX27, p.G216R and p.N333S in GLUT9 responsible for renal hypouricemia in three probands from Czech Republic and United Kingdom. Functional studies showed significantly decreased urate uptake for all variants. However, urate uptake of GLUT9 variants prepared for both isoforms were not significantly different.
CONCLUSIONS: This is the first complex function characterization of non-synonymous allelic variants in patients with renal hypouricemia regarding both GLUT9 isoforms. Our finding of defects in the SLC2A9 and SLC22A12 genes show the following: renal hypouricemia is not restricted to East Asia populations; urate uptake of GLUT9 variants prepared for both isoforms were not significantly different; renal hypouricemia type 2 has more wide clinical variability than type 1; the phenotypic severity of renal hypouricemia is not correlated with results of functional characterizations of URAT1 and GLUT9 variants.
Anzai,
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
2008, Pubmed,
Xenbase
Anzai,
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
2008,
Pubmed
,
Xenbase
Bhasin,
Hereditary renal hypouricemia: a new role for allopurinol?
2014,
Pubmed
Dehghan,
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.
2008,
Pubmed
Diaz-Torné,
New medications in development for the treatment of hyperuricemia of gout.
2015,
Pubmed
Dinour,
Homozygous SLC2A9 mutations cause severe renal hypouricemia.
2010,
Pubmed
,
Xenbase
Dinour,
URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews.
2011,
Pubmed
,
Xenbase
Enomoto,
Molecular identification of a renal urate anion exchanger that regulates blood urate levels.
2002,
Pubmed
,
Xenbase
Gabrikova,
High frequency of SLC22A12 variants causing renal hypouricemia 1 in the Czech and Slovak Roma population; simple and rapid detection method by allele-specific polymerase chain reaction.
2015,
Pubmed
Hurba,
Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
2014,
Pubmed
,
Xenbase
Ichida,
Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese.
2008,
Pubmed
Ichida,
Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion.
2004,
Pubmed
Iwai,
A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese.
2004,
Pubmed
Jeannin,
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity.
2014,
Pubmed
Karns,
Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia.
2012,
Pubmed
Kimura,
Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells.
2014,
Pubmed
Matsuo,
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.
2008,
Pubmed
Phay,
Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9).
2000,
Pubmed
Sebesta,
Diagnostic tests for primary renal hypouricemia.
2011,
Pubmed
Shima,
Recurrent EIARF and PRES with severe renal hypouricemia by compound heterozygous SLC2A9 mutation.
2011,
Pubmed
Stiburkova,
Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis.
2013,
Pubmed
,
Xenbase
Stiburkova,
Novel homozygous insertion in SLC2A9 gene caused renal hypouricemia.
2011,
Pubmed
Stiburkova,
Hereditary Renal Hypouricemia Type 1 and Autosomal Dominant Polycystic Kidney Disease.
2015,
Pubmed
,
Xenbase
Stiburkova,
Acute kidney injury in two children caused by renal hypouricaemia type 2.
2012,
Pubmed
Stiburkova,
Novel mutations in xanthine dehydrogenase/oxidase cause severe hypouricemia: biochemical and molecular genetic analysis in two Czech families with xanthinuria type I.
2012,
Pubmed
Taniguchi,
A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout.
2005,
Pubmed
Tasic,
Clinical and functional characterization of URAT1 variants.
2011,
Pubmed
Witkowska,
Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.
2012,
Pubmed
,
Xenbase
